Related Experiment Video
Updated: Mar 9, 2026

10:21
Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin
Published on: September 12, 2019
7.8K
Meta-Analytic Bayesian Model For Differentiating Intestinal Tuberculosis from Crohn's Disease.
Julajak Limsrivilai1,2, Andrew B Shreiner1, Ananya Pongpaibul3
1Division of Gastroenterology, University of Michigan, Ann Arbor, Michigan, USA.
The American Journal of Gastroenterology
|January 4, 2017
Summary
Differentiating intestinal tuberculosis (ITB) from Crohn's disease (CD) is challenging. A new Bayesian model, using clinical, endoscopic, and imaging findings, accurately predicts the probability of ITB versus CD.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Radiology
Background:
- Distinguishing intestinal tuberculosis (ITB) from Crohn's disease (CD) presents a significant clinical challenge.
- Various clinical, endoscopic, imaging, and laboratory findings have been reported to aid differentiation, but their predictive power requires quantification.
- A need exists for a comprehensive model to accurately estimate the probability of ITB versus CD.
Purpose of the Study:
- To estimate the predictive power of various findings in differentiating ITB from CD.
- To construct a comprehensive Bayesian prediction model for estimating the probability of ITB versus CD.
- To provide a tool for clinical application in differentiating these two conditions.
Main Methods:
- A systematic literature search was performed across MEDLINE, PUBMED, and EMBASE up to September 2015.
- Fifty-five meta-analyses were conducted to determine the odds ratio for each predictive finding.
- A Bayesian prediction model was developed, incorporating significant findings and local pretest probability.
Main Results:
- Thirty-eight studies involving 2,117 CD and 1,589 ITB patients were analyzed.
- Specific findings significantly favored either CD (e.g., male gender, perianal disease, cobblestone appearance) or ITB (e.g., fever, night sweats, ascites, positive interferon-γ release assay).
- The validated model demonstrated high diagnostic performance for ITB with 90.9% sensitivity, 92.6% specificity, and 91.8% accuracy.
Conclusions:
- A Bayesian model integrating meta-analytic results provides a robust method for estimating the probability of ITB versus CD.
- The model is calibrated to local disease prevalence, enhancing its clinical applicability.
- A publicly available web application facilitates the use of this model in patient management.

